Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. (Q53864503)

21 May 2018

title

Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. (English)

1 reference

21 May 2018

main subject

United States of America

0 references

1 reference

3

Brent K Hollenbeck

1 reference

21 May 2018

David C. Miller

1

object named as

David C Miller

1 reference

21 May 2018

author name string

Stephen B Gruber

2

1 reference

21 May 2018

James E Montie

4

1 reference

21 May 2018

John T Wei

5

1 reference

21 May 2018

language of work or name

English

0 references

publication date

1 August 2006

1 reference

21 May 2018

Journal of the National Cancer Institute

published in

1 reference

21 May 2018

volume

98

1 reference

21 May 2018

issue

16

1 reference

21 May 2018

page(s)

1134-1141

1 reference

21 May 2018

Radical prostatectomy versus watchful waiting in early prostate cancer

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

The changing face of low-risk prostate cancer: trends in clinical presentation and primary management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Prostate-specific antigen levels in the United States: implications of various definitions for abnormal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

The effectiveness of screening for prostate cancer: a nested case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Measuring the quality of care for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Active surveillance with selective delayed intervention: a biologically nuanced approach to favorable-risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Evidence-based quality improvement: the state of the science

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Quality of life after radical prostatectomy or watchful waiting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Utilities for prostate cancer health states in men aged 60 and older.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Do older men benefit from curative therapy of localized prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Continued undertreatment of older men with localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Some comments and data on the overtreatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

The business case for quality: case studies and an analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Patient education materials about the treatment of early-stage prostate cancer: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Racial/ethnic disparities in the treatment of localized/regional prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Partnership status influences quality of life in low-income, uninsured men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Self-reported use of shared decision-making among breast cancer specialists and perceived barriers and facilitators to implementing this approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Decision aids for people facing health treatment or screening decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

The application of the heuristic-systematic processing model to treatment decision making about prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

The male lumpectomy: rationale for a cancer targeted approach for prostate cryoablation. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Autoantibody signatures in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Delayed versus immediate surgical intervention and prostate cancer outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

Active surveillance for prostate cancer: for whom?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ308

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJJ308

1 reference

21 May 2018

PubMed ID

16912266

1 reference

21 May 2018